Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

05-27	Milestone Scientific Highlights Growing Clinical Adoption And Expanding Physician Acceptance Of CompuFlo Epidural System Across Epidural, Neuromodulation, And Interventional Pain Procedures	CI
05-14	Milestone Scientific Inc., Q1 2026 Earnings Call, May 14, 2026

Market Cap	30.05M 25.93M 23.84M 22.44M 42.16M 2.84B 42.51M 282M 110M 1.39B 113M 110M 4.82B	P/E 2026 *	-8.5x	P/E 2027 *	-9.71x
Enterprise Value	30.05M 25.93M 23.84M 22.44M 42.16M 2.84B 42.51M 282M 110M 1.39B 113M 110M 4.82B	EV / Sales 2026 *	3.05x	EV / Sales 2027 *	2.67x
Free-Float	79.47%	Yield 2026 *	-	Yield 2027 *	-

05-27	Milestone Scientific Highlights Growing Clinical Adoption And Expanding Physician Acceptance Of CompuFlo Epidural System Across Epidural, Neuromodulation, And Interventional Pain Procedures	CI
05-14	Milestone Scientific Inc., Q1 2026 Earnings Call, May 14, 2026
05-14	Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026	CI
05-13	Milestone Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-07	Milestone Scientific Inc. Expands National Sales Footprint and Clinical Engagement for Compuflo Medical Business	CI
04-21	Milestone Scientific Inc. completes $2.15 million private placement	RE
04-19	Milestone Scientific Inc. announced that it has received CAD 2.15 million in funding	CI
04-01	Milestone Scientific Inc., Q4 2025 Earnings Call, Apr 01, 2026
03-31	Milestone Scientific Inc. Provides Earnings Guidance for the Year Ending December 31, 2026	CI
03-31	Milestone Scientific Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-30	Milestone Scientific Inc. Auditor Raises 'Going Concern' Doubt	CI
01-20	Milestone Scientific enters amended MoU with Innovest S.P.A.	RE
11-14	Milestone Scientific Inc., Q3 2025 Earnings Call, Nov 14, 2025

20/11/24	Benchmark Company Downgrades Milestone Scientific to Speculative Buy	MT
10/10/24	Benchmark Initiates Milestone Scientific at Speculative Buy With $1.25 Price Target	MT
04/04/22	Maxim Adjusts Milestone Scientific's Price Target to $4 from $6, Keeps Buy Rating	MT

05-27	Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures	AQ
05-14	Milestone Scientific Reports Financial Results for First Quarter 2026	AQ
05-08	Milestone Scientific Expands CompuFlo Medical Business with Advisor Program and Growing National Clinical Adoption	AQ
05-07	Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call	AQ
05-07	Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption	AQ

Milestone Scientific Inc. Share Price Other OTC

Stocks

US59935P2092

Advanced Medical Equipment & Technology

Valuation: Milestone Scientific Inc.

Latest news : Milestone Scientific Inc.

Last Transcript: Milestone Scientific Inc.

Analysts' recommendations: Milestone Scientific Inc.

Press Releases: Milestone Scientific Inc.

Managers and Directors: Milestone Scientific Inc.

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Manager	Title	Age	Since
Eric Hines CEO	Chief Executive Officer	58	30/07/2025
Keisha Harcum DFI	Director of Finance/CFO	-	-
Mark Hochman CTO	Chief Tech/Sci/R&D Officer	65	31/12/1998

Director	Title	Age	Since
Neal Goldman CHM	Chairman	82	03/01/2023
Benedetta Casamento CHM	Chairman	56	31/12/2024
Didier Demesmin BRD	Director/Board Member	57	05/09/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERMO FISHER SCIENTIFIC, INC.	+0.15%	-2.82%	+17.75%	-12.35%	172B
INTUITIVE SURGICAL, INC.	+0.46%	-2.12%	-20.68%	+23.27%	142B
DANAHER CORPORATION	+0.17%	-1.83%	-8.72%	-24.99%	126B
BOSTON SCIENTIFIC CORPORATION	+0.10%	-4.27%	-55.46%	-16.44%	66.81B
EDWARDS LIFESCIENCES CORPORATION	+0.80%	+1.82%	+18.03%	-4.99%	49.91B
SIEMENS HEALTHINEERS AG	-0.63%	+0.09%	-24.40%	-34.27%	44.81B
AGILENT TECHNOLOGIES, INC.	+1.42%	-2.68%	+9.14%	+6.70%	35.11B
WATERS CORPORATION	-0.75%	-1.46%	+4.46%	+34.65%	35.05B
GE HEALTHCARE TECHNOLOGIES INC.	+0.65%	-4.36%	-14.17%	-21.80%	27.82B
Average	+0.19%	-3.15%	-8.23%	-5.58%	77.7B
Weighted average by Cap.	+0.21%	-3.30%	-6.88%	-5.70%

	2026 *	2027 *
Net sales	9.86M 8.51M 7.82M 7.36M 13.83M 931M 13.95M 92.68M 36.08M 457M 37.01M 36.22M 1.58B	11.25M 9.71M 8.92M 8.4M 15.78M 1.06B 15.91M 106M 41.17M 521M 42.23M 41.32M 1.8B
Net income	-3.22M -2.77M -2.55M -2.4M -4.51M -304M -4.55M -30.23M -11.77M -149M -12.07M -11.81M -515M	-2.91M -2.51M -2.31M -2.17M -4.08M -274M -4.11M -27.33M -10.64M -135M -10.91M -10.68M -466M
Net Debt	-	-

End-of-day quote Other OTC Other stock markets
- ^USD	-